Posts Tagged: medical diagnositcs


6 Years Later: The Effects of the Mayo Decision on Diagnostic Methods

2018 celebrates the six-year anniversary of one of the most important Supreme Court decisions of the modern era. On March 20, 2012, the Court handed down its ruling in Mayo …
By Shai Jalfin
10 months ago 3

Abbott Labs acquires large Alere patent portfolio in $5.8 billion deal, increasing diagnostic lineup

Abbott Laboratories (NYSE:ABT) of Chicago, IL, is poised to surge ahead in the global point-of-care medical diagnostics industry by acquiring Alere Inc. (NYSE:ALR) of Waltham, …
By Steve Brachmann
3 years ago 1

Canon already with more than 300 patents in 2016, pursues plastics and photoacoustic imaging tech

Our latest survey of patents issued recently to Canon include a couple of imaging technologies related to medical diagnostics, such as is the case with the imaging …
By Steve Brachmann
3 years ago 0

Ariosa v. Sequenom: Petitioning the Federal Circuit to Reverse Course on Patent Eligibility

This is a really important question both with respect to biologics and other interventions and also as the Federal Circuit does work with the Supreme Court’s …
By Gene Quinn
4 years ago 36

Johns Hopkins Seeks Patent on Surgical Robot Systems

The medical research university is heavily involved with developments for medical diagnostics, as many of the following applications show. One patent application describes a system of searching …
By Steve Brachmann
6 years ago 0

Siemens Seeks Patent on Mobile Privacy System for Accessing Cloud Computing Resources

Many of these patent references reviewed this week show us Siemens involvement with electrical and Internet systems on all levels, from personal to industrial. For example, one …
By Steve Brachmann
6 years ago 2

Throwing Down the Gauntlet: Rader Rules in Utramercial that Breadth and Lack Specificity Does Not Make Claimed Method Impermissibly Abstract*

Some will undoubtedly view the Chief Judge’s basis in Ultramercial for distinguishing the ruling in CyberSource as being “slight of hand” and using “mirrors,” but it …
By Eric Guttag
8 years ago 25

CAFC on Patent-Eligibility: A Firestorm of Opinions in Classen*

That there was a majority (and a dissenting) opinion in the remand of Classen wasn’t surprising. But that there was yet a third “additional views” opinion …
By Eric Guttag
8 years ago 15

Prometheus Diagnostic Methods Are Patentable Subject Matter

United States Court of Appeals for the Federal Circuit issued a decision in one of the patentable subject matter cases that was returned to the Court by …
By Gene Quinn
8 years ago 2

Jumping Down the Rabbit Hole: Federal Circuit Ducks the Patent-Eligibility Issue in King Pharmaceuticals

With an opportunity to render some order out of the Bilski chaos, the Federal Circuit instead completely ducked the patent-eligibility issue clearly presented in King Pharmaceuticals. The …
By Eric Guttag
9 years ago 10

Through the Fuzzy Bilski Looking Glass: The Meaning of Patent-Eligible under 35 U.S.C. § 101

So now what does SCOTUS’ ruling in Bilski “really” mean to us “mere mortals”? First, we’ve got two “wild cards” to deal with as noted above: (1) …
By Eric Guttag
9 years ago 74

Foaming at the Mouth III: And Then Came Bilski

One reason I was quite interested in Bilski was because the Supreme Court (not surprisingly) ruled that the Federal Circuit’s “machine or transformation” test was too …
By Eric Guttag
9 years ago 29

Diagnostic Testing in the Wake of Bilski v. Kappos

Now that the Supreme Court has vacated and remanded both the Classen and Prometheus decisions, the Federal Circuit must revisit these issues. For Prometheus, the decision may …

CAFC Judge Plager Says Definiteness Requirement Needs Teeth

As I’ve said before, no one could rightly accuse me of being biased against patents. But, as I also pointed out in this article on Judge …
By Eric Guttag
9 years ago 1

Foaming at the Mouth II: My Alternative to the New But Inane Becerra Bill

I do have a suggested alternative on the patenting of gene sequences that is far more sensible (and won’t kill our biotech sector) than the “all …
By Eric Guttag
9 years ago 75